130 related articles for article (PubMed ID: 38296497)
1. [Metabolic Activities Catalyzed by Human Cytochrome P450 (CYP) 2D6 and CYP3A Subfamily Members and Effect of Various Compounds, Including Endogenous Steroid Hormones, on These Activities].
Niwa T
Yakugaku Zasshi; 2024; 144(2):197-202. PubMed ID: 38296497
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the human cytochrome P450 2C subfamily to the metabolism of and the interactions with endogenous compounds including steroid hormones.
Niwa T; Yasuda S; Yamamoto Y; Murakami M; Ishii R
Pharmazie; 2021 Dec; 76(12):611-613. PubMed ID: 34986958
[TBL] [Abstract][Full Text] [Related]
3. Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies.
Niwa T; Okamoto A; Narita K; Toyota M; Kato K; Kobayashi K; Sasaki S
Arch Biochem Biophys; 2020 Mar; 682():108283. PubMed ID: 32001245
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory and Inhibitory Effects of Steroid Hormones and Human Cytochrome P450 (CYP) 3A Inhibitors on Cortisol 6β-Hydroxylation Catalyzed by CYP3A Subfamilies.
Niwa T; Tani M; Suzuki A; Murakami M
Drug Metab Bioanal Lett; 2023; 16(2):73-80. PubMed ID: 37649294
[TBL] [Abstract][Full Text] [Related]
5. Effect of Human Cytochrome P450 2D6 Polymorphism on Progesterone Hydroxylation.
Niwa T; Sasaki S; Yamamoto Y; Tanaka M
Eur J Drug Metab Pharmacokinet; 2022 Sep; 47(5):741-747. PubMed ID: 35838883
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Stimulatory and Inhibitory Effects of Steroid Hormones and α-Naphthoflavone on Steroid Hormone Hydroxylation Catalyzed by Human Cytochrome P450 3A Subfamilies.
Niwa T; Toyota M; Kawasaki H; Ishii R; Sasaki S
Biol Pharm Bull; 2021; 44(4):579-584. PubMed ID: 33790108
[TBL] [Abstract][Full Text] [Related]
7. Effect of genetic polymorphism on the inhibition of dopamine formation from p-tyramine catalyzed by brain cytochrome P450 2D6.
Niwa T; Shizuku M; Yamano K
Arch Biochem Biophys; 2017 Apr; 620():23-27. PubMed ID: 28347660
[TBL] [Abstract][Full Text] [Related]
8. Role of amino acids at positions 34, 296, and 486 of cytochrome P450 2D6 in the stimulatory and inhibitory effects of psychotropic agents on dopamine formation from
Niwa T; Arima J; Michihiro Y
Xenobiotica; 2021 Nov; 51(11):1229-1235. PubMed ID: 34605737
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory and Stimulatory Effects of Selective Serotonin Reuptake Inhibitors on Cytochrome P450 2D6-mediated Dopamine Formation from p-Tyramine.
Niwa T; Sugimoto S
J Pharm Pharm Sci; 2019; 22(1):585-592. PubMed ID: 31804922
[TBL] [Abstract][Full Text] [Related]
10. Effect of Cytochrome P450 (CYP) 2D6 Genetic Polymorphism on the Inhibitory Action of Antidepressants on CYP2D6-Mediated Dopamine Formation from p-Tyramine.
Niwa T; Yanai M; Matsumoto M; Shizuku M
J Pharm Pharm Sci; 2018; 21(1):135-142. PubMed ID: 29602316
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Steroid Hormone Hydroxylations by and Docking to Human Cytochromes P450 3A4 and 3A5.
Niwa T; Narita K; Okamoto A; Murayama N; Yamazaki H
J Pharm Pharm Sci; 2019; 22(1):332-339. PubMed ID: 31339834
[TBL] [Abstract][Full Text] [Related]
12. Stimulatory and inhibitory effect of antipsychotic agents including dopaminergic neuro-depressants on dopamine formation from p-tyramine mediated by cytochrome P450 2D6.
Niwa T; Yamamoto Y
Drug Metab Bioanal Lett; 2023 Sep; ():. PubMed ID: 37711131
[TBL] [Abstract][Full Text] [Related]
13. Regioselective hydroxylation of steroid hormones by human cytochromes P450.
Niwa T; Murayama N; Imagawa Y; Yamazaki H
Drug Metab Rev; 2015 May; 47(2):89-110. PubMed ID: 25678418
[TBL] [Abstract][Full Text] [Related]
14. Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6.
Niwa T; Hiroi T; Tsuzuki D; Yamamoto S; Narimatsu S; Fukuda T; Azuma J; Funae Y
Brain Res Mol Brain Res; 2004 Oct; 129(1-2):117-23. PubMed ID: 15469888
[TBL] [Abstract][Full Text] [Related]
15. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Ball SE; Ahern D; Scatina J; Kao J
Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
[TBL] [Abstract][Full Text] [Related]
16. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.
Yamazaki H; Shimada T
Arch Biochem Biophys; 1997 Oct; 346(1):161-9. PubMed ID: 9328296
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions.
Wójcikowski J; Danek PJ; Basińska-Ziobroń A; Pukło R; Daniel WA
Pharmacol Rep; 2020 Jun; 72(3):612-621. PubMed ID: 32219694
[TBL] [Abstract][Full Text] [Related]
19. Involvement of human cytochrome P450 3A4 in reduced haloperidol oxidation.
Kudo S; Odomi M
Eur J Clin Pharmacol; 1998 May; 54(3):253-9. PubMed ID: 9681669
[TBL] [Abstract][Full Text] [Related]
20. Steroid hydroxylation by human fetal CYP3A7 and human NADPH-cytochrome P450 reductase coexpressed in insect cells using baculovirus.
Ohmori S; Fujiki N; Nakasa H; Nakamura H; Ishii I; Itahashi K; Kitada M
Res Commun Mol Pathol Pharmacol; 1998 Apr; 100(1):15-28. PubMed ID: 9644715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]